definiens: means ( i)any-24 - AZandCKConfidentiaLprototypes provided byCKunderthisAgreement orinconnection withtheResearch Program;(ii)information disclosed intangible formthatismarked orwithothersimilardesignation toindicate itsconfidential orproprietary nature ; and(iii)information disclosedorally, where suchinformation iseither ( A)ofthetypeusually considered confidential orproprietary inthebiopharmaceutical industry or(B)otherwise indicated tobeconfidential orproprietary bythedisclosing Partyatthetimeoftheinitialdisclosure thereof andconfirmed inwriting asconfidential orproprietary bythedisclosing Partywithin thirty(30)daysaftersuchdisclosure . Notwithstanding theforegoing, Confidential Information shallnotincludeinformation that, ineachcaseasdemonstrated bywritten documentation:(a)wasalready orbecomes lawfully known tothereceiving Party, otherthanunderanobligation ofconfidentiality, atthetimeofdisclosure;(b)canbedemonstrated bydocumentation orothercompetent prooftohavebeeninthereceiving Party 's oritsAffiliates ' possession priortodisclosure bythedisclosing Party;(c)issubsequently received bythereceiving PartyoritsAffiliates fromaThird Partywhoisnotbound byanyobligation ofconfidentiality withrespect tothatinformation;(d)isgenerally madeavailable toThirdParties bythedisclosing Partywithout restriction ondisclosure;(e)wasgenerally available tothepublic orotherwise partofthepublicdomain atthetimeofitsdisclosure tothereceiving Partyorbecame generally available tothepublicorotherwise partofthepublic domain afteritsdisclosure andotherthanthrough anyactoromission ofthereceiving Partyinbreach ofthisAgreement ; or(f)wasdeveloped bythereceiving Partywithout reference toanyinformation ormaterials disclosed orprovided bythedisclosing Party